We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 150.00 | 140.00 | 160.00 | 150.00 | 150.00 | 150.00 | 50 | 07:44:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -28.73M | -0.4177 | -3.59 | 103.18M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/5/2018 11:28 | How when my average is £1.10 on 30k shares loooool | kirk 6 | |
10/5/2018 10:54 | Looks like a bunch of Gamblers gonna get spiked here, MM's laughing | boxerdogz | |
10/5/2018 10:32 | I bought some IMM today!!!! STILL HOLDING FARN...Expecting some profiting taking but im in this for long term. 1 years plus! | jayj4u | |
10/5/2018 10:28 | Further investigations are currently underway to provide additional information on the outcome of the current analysis | hope67 | |
10/5/2018 10:28 | They seem surprised by the results compared to other studies Dr Markku Jalkanen, CEO of Faron, said: "We are incredibly disappointed and surprised by these results. We need to further analyse the data in order to understand how this study differs from our previous positive results with ARDS patients, both in terms of Traumakine's efficacy, and in the unusually low mortality rate observed in the placebo arm. We look forward to the results of the Japanese study in Q3 2018 and will be considering how we can advance Traumakine in clinical development. "We will continue our plans to advance our next asset, Clevegen, our second candidate which is a ground breaking anti-Clever-1 antibody, into clinical development in solid cancers later this year. | hope67 | |
10/5/2018 09:17 | Short squeeze.. Should break 200p easy at this rate | letmepass | |
10/5/2018 09:05 | NT to buy..proving difficult to get stock here | pre | |
10/5/2018 09:04 | I'm thinking this could hit 600p before that with a director buy as well.. All speculation of course | shirley83 | |
10/5/2018 09:03 | True.. Difficult to predict but they can have another go in Japan.. Maybe it works? | shirley83 | |
10/5/2018 09:00 | Shirley8310 - "Well done Pwhite but pharma stocks you have no clue about.." And neither does this company after what has happened of late. | pwhite73 | |
10/5/2018 08:53 | Short squeeze this could hit 600p | shirley83 | |
10/5/2018 08:51 | Come to daddy | kirk 6 | |
10/5/2018 08:49 | NT to buy...get ready... | pre | |
10/5/2018 08:46 | Squeeze coming as mms run short | shirley83 | |
10/5/2018 08:45 | Yes, anyone who bought them at around £1... has made over 60%! But I'm waiting for much more...I think minimum £2 by this week!! | jayj4u | |
10/5/2018 08:44 | Well done Pwhite but pharma stocks you have no clue about.. | shirley83 | |
10/5/2018 08:43 | Every stock is different. This has another 3p... even the yesterday news I treat cautiously. | jayj4u | |
10/5/2018 08:42 | should see a break past £1.70 shortly... | pre | |
10/5/2018 08:42 | inv - "should be 300p plus on Japanese news" The Japanese study would have used the same methodology as the US/European study. Even if they came out positive. Phase III has still failed. | pwhite73 | |
10/5/2018 08:38 | IMM initially bounced it is now trading at its lowest ever. The same will happen to this stock when the shorts and longs have finished battling it out. The stock is rising to burn the shorts still open from the initial drop. The TR1 yesterday was Polar Capital reducing its holding. | pwhite73 | |
10/5/2018 08:34 | should be 3oop plus on Japanese news | inv | |
10/5/2018 08:33 | This drop is way over done! I'm in at £1.45... looking for £2.30-£2.50 plus... I might just hold for next p3! | jayj4u | |
10/5/2018 08:32 | Thinking 300p easy.. Way oversold and more to come | shirley83 | |
10/5/2018 08:29 | Looks like +£2 likely here...NT to buy and big squeeze on the way? | pre | |
10/5/2018 07:47 | Hopefully a nice steady rise.. Way oversold with so much in the pipeline.. Read the RNS | shirley83 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions